The search for new drugs that can target medullary thyroid cancer is on-going.
Here's a new approach that is coming to light. It's a long way off being ready for use, but it's encouraging to see progress, particularly using an approach that is a bit different.
Some of the current drugs target some of the biochemical machinery inside the cells, whereas this approach aims to attach a radioactive molecule to something that sticks to or gets taken up by the medullary thyroid cancer cell.
Whilst it's perhaps unlikely that any drug will be 100% effective, having a range of different drugs or different strategies might work well together.